Page last updated: 2024-10-27

gabexate and Anaphylaxis

gabexate has been researched along with Anaphylaxis in 3 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sendo, T1
Sumimura, T1
Itoh, Y1
Goromaru, T1
Aki, K1
Yano, T1
Oike, M1
Ito, Y1
Mori, S1
Nishibori, M1
Oishi, R1
Matsukawa, Y2
Nishinarita, S2
Sawada, S1
Horie, T2
Naruse, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)[NCT02673840]Phase 4110 participants (Anticipated)Interventional2015-03-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for gabexate and Anaphylaxis

ArticleYear
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
    Cellular signalling, 2003, Volume: 15, Issue:8

    Topics: Actins; Anaphylaxis; Animals; Antigens, CD; Aorta; Benzamidines; Cadherins; Calcium Signaling; Capil

2003
Fatal cases of gabexate mesilate-induced anaphylaxis.
    International journal of clinical pharmacology research, 2002, Volume: 22, Issue:3-4

    Topics: Anaphylaxis; Fatal Outcome; Female; Gabexate; Humans; Male; Middle Aged; Pancreatitis; Serine Protei

2002
Anaphylaxis induced by gabexate mesylate.
    BMJ (Clinical research ed.), 1998, Dec-05, Volume: 317, Issue:7172

    Topics: Adult; Aged; Anaphylaxis; Female; Gabexate; Humans; Male; Middle Aged; Serine Proteinase Inhibitors

1998